NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood†) today issued the following letter to the Board of Directors (the "Board†) of STAAR Surgical Company ("STAAR†or the "Company†) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR's outstanding common shares, continues to urge its fellow shareholders to vote on its GREEN Proxy Card "AGAINST†the proposed acquisition of STAAR by Alcon Inc. ("Alcon†) (NYSE: ALC) on the terms announced August 5, 2025. ...